Why the study?
Does abstention from alcohol improve clinical status and outcomes in patients with alcoholic cardiomyopathy?
Does abstention from alcohol improve clinical status and outcomes in patients with alcoholic cardiomyopathy?
Abstention from alcohol and a shorter duration of symptoms before initiation of therapy are associated with a more favorable clinical course and improved survival in alcoholic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Alcohol abstinence was associated with improved status in alcoholic cardiomyopathy; leaves open causality and requires RCTs before practice change.
Fifty-seven patients with cardiomyopathy associated with alcoholism were followed for an average of 40.5 months (range, 4 months to 8 years). None of the patients were treated with prolonged bed rest. During the follow-up period, the clinical status improved in 15 patients (group A), was stable in 12 patients (group B), and had deteriorated in 30 patients (group C). Seventy-three percent of the group A patients abstained from alcohol, whereas in groups B and C only 25% and 13% of patients, respectively, abstained. These differences were significant—P < 0.03 (group A versus B) and P < 0.001 (group A versus C). The average duration of symptoms in the group A patients was 4.2 months and was significantly (P < 0.05) shorter than that of patients in groups B and C (17 and 11.1 months, respectively). Only 10 patients (17%), all in group A, had a return of heart size to normal. Twenty-four patients (42%), all in group C, died in an average time of 36 months; thus, a short duration of symptoms before initiation of therapy and abstention from alcohol were associated with a more favorable course.
No takes yet. Share an insight, caveat, or question.
John G. Demakis (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: